Literature DB >> 9352274

Causes of enucleation: a clinicopathological study.

I Günalp1, K Gündüz, M Ozkan.   

Abstract

BACKGROUND: Enucleation is an approach used for unresponsive end-stage ocular disease often resulting in blind, painful or cosmetically unacceptable eyes.
METHODS: We reviewed the clinicopathological data on 3506 enucleations performed over a 50-year period, 1945-1995. Histopathological data were divided into eight groups according to the causes leading to enucleation: trauma, phthisis, corneal disease, inflammation, vitreoretinal disease, glaucoma, tumors and infections.
RESULTS: The study considered 3506 enucleated eyes of 3482 patients, 2467 (70.8%) males and 1011 (29.1%) females (4 sex unspecified). The z-test showed there were significantly more enucleations in males for phthisis (p < 5.05), infections (p < 0.01), trauma (p < 0.01) and inflammation (p < 0.01) and more enucleations for tumors in females (p < 0.01). There were no differences between males and females with regard to enucleations for glaucoma, vitreoretinal and corneal diseases (p > 0.05). The 0-9 years age group was most frequently affected, accounting for 29.7% of the cases. Patients aged less than 30 years constituted 53.6% of all enucleations. The primary or underlying causes leading to enucleation were tumors (1185 eyes, 33.8%), phthisis (587 eyes, 16.7), glaucoma (561 eyes, 16.0%), vitreoretinal diseases (320 eyes, 9.1%), infections (259 eyes, 7.4%), corneal disease (229 eyes, 6.5%), trauma (209 eyes, 6.0%) and inflammation (156 eyes, 4.4%). Time trends in enucleating eyes with different causes showed the number of enucleations for phthisis, infections, corneal diseases, trauma and inflammations had dropped during the ten-year period 1986-1995 compared to 1976-1985 (z-test, p < 0.01). There were no real changes in enucleations for glaucoma and vitreoretinal diseases and there was an increase in the number of enucleations for tumors (p < 0.01).
CONCLUSIONS: Improved diagnostic and therapeutic methods, widespread use of photocoagulation in vascular disorders and vitreoretinal surgery in traumas, effective antimicrobial treatment, increasing use of corticosteroids and immunosuppressants, have contributed to the decreasing frequency of enucleation. Tumor patients generally presented late with advanced tumors totally filling the eye, not salvageable by other non-invasive treatment methods. Prompt diagnosis of intraocular malignant tumors (retinoblastoma and malignant melanoma) may reduce the need for enucleation.

Entities:  

Mesh:

Year:  1997        PMID: 9352274     DOI: 10.1177/112067219700700304

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  10 in total

1.  Indications for eye removal in southern Nigeria.

Authors:  Affiong Ibanga; Uduak Asana; Dennis Nkanga; Roseline Duke; Bassey Etim; Olugbemisola Oworu
Journal:  Int Ophthalmol       Date:  2012-12-29       Impact factor: 2.031

2.  Painful blind eye: efficacy of enucleation and evisceration in resolving ocular pain.

Authors:  S D Shah-Desai; A G Tyers; R M Manners
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

3.  Social determinants associated with loss of an eye in the United States using the All of Us nationwide database.

Authors:  Alison X Chan; Bharanidharan Radha Saseendrakumar; Daniel J Ozzello; Michelle Ting; Jin Sook Yoon; Catherine Y Liu; Bobby S Korn; Don O Kikkawa; Sally L Baxter
Journal:  Orbit       Date:  2021-12-30

4.  Changing causes of enucleation over the past 60 years.

Authors:  Vikram J Setlur; Jignesh G Parikh; Narsing A Rao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-17       Impact factor: 3.117

Review 5.  Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region.

Authors:  Priscilla Xinhui Wang; Victor Teck Chang Koh; Katherine Lun; Gangadhara Sundar
Journal:  Int Ophthalmol       Date:  2013-10-02       Impact factor: 2.031

6.  Clinicopathological Review of 547 Bulbar Enucleations in Hungary (2006-2017).

Authors:  Gábor Tóth; Nóra Szentmáry; Gábor László Sándor; Béla Csákány; Erika Maka; Jeannette Tóth; Zsuzsanna Antus; Milán Tamás Pluzsik; Achim Langenbucher; Zoltán Zsolt Nagy; Olga Lukáts
Journal:  J Ophthalmol       Date:  2019-02-14       Impact factor: 1.909

7.  Evaluation of the Demographic Features of Eye Loss in Turkey.

Authors:  Korhan Fazil
Journal:  Beyoglu Eye J       Date:  2019-12-19

8.  Clinical Review of Ocular Traumas Resulting in Enucleation or Evisceration in a Tertiary Eye Care Center in Hungary.

Authors:  Gábor Tóth; Milán Tamás Pluzsik; Béla Csákány; Gábor László Sándor; Olga Lukáts; Zoltán Zsolt Nagy; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2021-05-27       Impact factor: 1.909

9.  Fifteen-year trends in indications for enucleation from a tertiary care center in South India.

Authors:  Sabyasachi Sengupta; Subramanian Krishnakumar; Jyotirmay Biswas; Lingam Gopal; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2012 May-Jun       Impact factor: 1.848

10.  Indications for eye removal surgeries. A 15-year experience at a tertiary military hospital.

Authors:  Mehmet T Koylu; Gokcen Gokce; Yusuf Uysal; Osman M Ceylan; Dorukcan Akıncıoglu; Armagan Gunal
Journal:  Saudi Med J       Date:  2015-10       Impact factor: 1.484

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.